The use of rapid diagnostic test of Procalcitonin serum levels for the postmortem diagnosis of sepsis

Forensic Science International

Volumn 178, Issue 2-3, 2008, Pages 139-145

  Ramsthaler, Frank ^a   Kettner, Mattias ^a   Mall, Gerhard ^b   Bratzke, Hansjuergen ^a  

^a GOETHE UNIVERSITY   (Germany)

^b KLINIKUM DARMSTADT   (Germany)

Author keywords

Forensic pathology; Postmortem diagnosis; Procalcitonin; Sepsis; SIRS

Indexed keywords

PROCALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL DECISION MAKING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS;

EID: 44349141708     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2008.03.010     Document Type: Article

References (41)

1. Gattas D.J., and Cook D.J. Procalcitonin as a diagnostic test for sepsis: health technology assessment in the ICU. J. Crit. Care 18 (2003) 52-58
2. Guerin S. Evaluation of the detection of procalcitonin by an immuno-chromatography test: Brahms PCT-Q. Ann. Biol. Clin. (Paris) 58 (2000) 613-614
3. Meisner M., Tschaikowsky K., Palmaers T., and Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit. Care (Lond.) 3 (1999) 45-50
4. Meisner M. Procalcitonin (PCT) Ein neuer, innovativer Infektionsparameter. Biochemische und klinische Aspekte (2000), Georg Thieme Verlag, Stuttgart, New York
5. Meisner M., Adina H., and Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit. Care 10 (2006) R1
6. Mimoz O., Benoist J.F., Edouard A.R., Assicot M., Bohuon C., and Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 24 (1998) 185-188
7. Fraunberger P., Wang Y., Holler E., Parhofer K.G., Nagel D., Walli A.K., and Seidel D. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 26 (2006) 10-12
8. Dorizzi R.M., Polati E., Sette P., Ferrari A., Rizzotti P., and Luzzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin. Biochem. 39 (2006) 1138-1143
9. Jensen J.U., Heslet L., Jensen T.H., Espersen K., Steffensen P., and Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit. Care Med. 34 (2006) 2596-2602
10. Meisner M., Brunkhorst F.M., Reith H.B., Schmidt J., Lestin H.G., and Reinhart K. Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin. Chem. Lab Med. 38 (2000) 989-995
11. Meisner M. Biomarkers of sepsis: clinically useful?. Curr. Opin. Crit. Care 11 (2005) 473-480
12. O'Connor E., Venkatesh B., Lipman J., Mashongonyika C., and Hall J. Procalcitonin in critical illness. Crit. Care Resusc. 3 (2001) 236-243
13. Reinhart K., Meisner M., and Brunkhorst F.M. Markers for sepsis diagnosis: what is useful?. Crit. Care Clin. 22 (2006) 503-550
14. Uzzan B., Cohen R., Nicolas P., Cucherat M., and Perret G.Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit. Care Med. 34 (2006) 1996-2003
15. Heper Y., Akalin E.H., Mistik R., Akgoz S., Tore O., Goral G., Oral B., Budak F., and Helvaci S. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur. J. Clin. Microbiol. Infect. Dis. 25 (2006) 481-491
16. Boussekey N., Leroy O., Alfandari S., Devos P., Georges H., and Guery B. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med. 32 (2006) 469-472
17. Masia M., Gutierrez F., Shum C., Padilla S., Navarro J.C., Flores E., and Hernandez I. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest 128 (2005) 2223-2229
18. Sands K.E., Bates D.W., Lanken P.N., Graman P.S., Hibberd P.L., Kahn K.L., Parsonnet J., Panzer R., Orav E.J., Snydman D.R., Black E., Schwartz J.S., Moore R., Johnson Jr. B.L., and Platt R. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278 (1997) 234-240
19. Meisner M., Tschaikowsky K., Schnabel S., Schmidt J., Katalinic A., and Schuttler J. Procalcitonin-influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur. J. Clin. Chem. Clin. Biochem. 35 (1997) 597-601
20. Tsokos M., Reichelt U., Nierhaus A., and Puschel K. Serum procalcitonin (PCT): a valuable biochemical parameter for the post-mortem diagnosis of sepsis. Int. J. Legal Med. 114 (2001) 237-243
21. Tsokos M. Postmortem measurement of serum procalcitonin concentration in Waterhouse-Friderichsen syndrome. Virchows Arch. 441 (2002) 629-631
22. BRAHMS PCT-Q and Brahms Diagnostica GmbH, Operating Instruction, Chapter 1-6, Germany, 2002.
23. Giamarellos-Bourboulis E.J., Giannopoulou P., Grecka P., Voros D., Mandragos K., and Giamarellou H. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?. J. Crit. Care 19 (2004) 152-157
24. Casado-Flores J., Blanco-Quiros A., Nieto M., Asensio J., and Fernandez C. Prognostic utility of the semi-quantitative procalcitonin test, neutrophil count and C-reactive protein in meningococcal infection in children. Eur. J. Pediatr. 165 (2006) 26-29
25. Aouifi A., Piriou V., Bastien O., Blanc P., Bouvier H., Evans R., Celard M., Vandenesch F., Rousson R., and Lehot J.J. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit. Care Med. 28 (2000) 3171-3176
26. Baykut D., Schulte-Herbruggen J., and Krian A. The value of procalcitonin as an infection marker in cardiac surgery. Eur. J. Med. Res. 5 (2000) 530-536
27. Hammer S., Fraunberger P., Meiser B., Stangl M., Seidel D., and Hammer C. Procalcitonin, a new indicator for non-viral infections in heart, lung or liver transplant patients. Ann. Transplant. 4 (1999) 5-9
28. Jaresova M., Striz I., Cermakova J., Lacha J., Sedlacek J., Mudra K., Hana I., and Vitko S. Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunol. Lett. 69 (1999) 355-358
29. Kindberg B.A., Madsen J.S., and Jorgensen P.E. Procalcitonin as a marker of postoperative complications. Scand. J. Clin. Lab Invest. 65 (2005) 387-394
30. Meisner M., Tschaikowsky K., Hutzler A., Schick C., and Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 24 (1998) 680-684
31. Benoist J.F., Mimoz O., Assicot M., and Edouard A. Serum procalcitonin, but not C-reactive protein, identifies sepsis in trauma patients. Clin. Chem. 44 (1998) 1778-1779
32. Pepe M.S. The Statistical Evaluation of Medical Tests for Classification and Prediction (2003), Oxford University Press, Oxford
33. Gramm H.J., Hannemann L., Reinhart K., and Lode H. Sepsis: ein Begriff im Wandel. Möglichkeiten und Grenzen der Diagnose anhand klinischer Kriterien. Dtsch. Med. Wochenschr. 120 (1995) 498-502
34. Riede U.-N., Werner M., and Schäfer H.E. Allgemeine und spezielle Pathologie (2003), Thieme, Stuttgart
35. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Crit. Care Med. 20 (1992) 864-874.
36. Cohen I.L. Definitions for sepsis and organ failure. The ACCP/SCCM Consensus Conference Committee Report. Chest 103 (1993) 656
37. R.C. Bone, R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, R.M. Schein, W.J. Sibbald, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine, Chest 101 (1992) 1644-1655.
38. Bone R.C., Sibbald W.J., and Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101 (1992) 1481-1483
39. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., Cohen J., Opal S.M., Vincent J.L., and Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31 (2003) 1250-1256
40. Christ-Crain M., and Muller B. Procalcitonin in bacterial infections. Hype, hope, more or less?. Swiss. Med. Wkly. 135 (2005) 451-460
41. Christ-Crain M., and Muller B. Procalictonin. You only find what you look for, and you only look for what you know. J. Am. Geriatr. Soc. 54 (2006) 546-548